Allianz Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.25M | Sell |
36,990
-27,716
| -43% | -$5.38M | 0.01% | 1002 |
|
|
2025
Q4 | $11.2M | Sell |
64,706
-93,144
| -59% | -$17M | 0.01% | 808 |
|
|
2025
Q3 | $30.1M | Sell |
157,850
-146,511
| -48% | -$26M | 0.03% | 450 |
|
|
2025
Q2 | $54.7M | Sell |
304,361
-84,694
| -22% | -$14.7M | 0.07% | 299 |
|
|
2025
Q1 | $65.8M | Sell |
389,055
-131,556
| -25% | -$21.6M | 0.09% | 229 |
|
|
2024
Q4 | $78.5M | Sell |
520,611
-95,252
| -15% | -$14.8M | 0.1% | 205 |
|
|
2024
Q3 | $95.6M | Buy |
615,863
+320,763
| +109% | +$47.9M | 0.13% | 164 |
|
|
2024
Q2 | $40.4M | Buy |
295,100
+34,572
| +13% | +$4.73M | 0.06% | 317 |
|
|
2024
Q1 | $34.7M | Buy |
260,528
+21,372
| +9% | +$2.77M | 0.05% | 339 |
|
|
2023
Q4 | $33M | Buy |
239,156
+5,285
| +2% | +$695K | 0.05% | 343 |
|
|
2023
Q3 | $28.5M | Buy |
233,871
+68,625
| +42% | +$9.14M | 0.05% | 378 |
|
|
2023
Q2 | $23.2M | Buy |
165,246
+29,543
| +22% | +$4.07M | 0.04% | 416 |
|
|
2023
Q1 | $19.2M | Sell |
135,703
-106,531
| -44% | -$15.2M | 0.03% | 493 |
|
|
2022
Q4 | $37.9M | Sell |
242,234
-15,918
| -6% | -$2.29M | 0.07% | 283 |
|
|
2022
Q3 | $31.7M | Sell |
258,152
-33,178
| -11% | -$4.37M | 0.06% | 314 |
|
|
2022
Q2 | $38.7M | Buy |
291,330
+1,572
| +0.5% | +$214K | 0.04% | 481 |
|
|
2022
Q1 | $39.7M | Buy |
289,758
+149,261
| +106% | +$20.8M | 0.03% | 528 |
|
|
2021
Q4 | $24.3M | Sell |
140,497
-29,337
| -17% | -$4.46M | 0.02% | 698 |
|
|
2021
Q3 | $24.7M | Sell |
169,834
-174,435
| -51% | -$25.5M | 0.02% | 650 |
|
|
2021
Q2 | $45.4M | Sell |
344,269
-170,463
| -33% | -$22.3M | 0.04% | 419 |
|
|
2021
Q1 | $66.1M | Sell |
514,732
-358,805
| -41% | -$44.2M | 0.06% | 300 |
|
|
2020
Q4 | $104M | Buy |
873,537
+90,419
| +12% | +$11M | 0.1% | 195 |
|
|
2020
Q3 | $89.7M | Buy |
783,118
+220,845
| +39% | +$26.1M | 0.1% | 204 |
|
|
2020
Q2 | $64.1M | Sell |
562,273
-87,774
| -14% | -$9.31M | 0.07% | 279 |
|
|
2020
Q1 | $52.2M | Sell |
650,047
-350,069
| -35% | -$36.2M | 0.07% | 300 |
|
|
2019
Q4 | $107M | Buy |
1,000,116
+45,174
| +5% | +$4.71M | 0.1% | 228 |
|
|
2019
Q3 | $102M | Sell |
954,942
-590,562
| -38% | -$60.6M | 0.1% | 228 |
|
|
2019
Q2 | $157M | Sell |
1,545,504
-331,475
| -18% | -$31.9M | 0.15% | 147 |
|
|
2019
Q1 | $169M | Sell |
1,876,979
-106,622
| -5% | -$9.24M | 0.17% | 120 |
|
|
2018
Q4 | $165M | Buy |
1,983,601
+92,647
| +5% | +$8.69M | 0.18% | 118 |
|
|
2018
Q3 | $204M | Sell |
1,890,954
-133,319
| -7% | -$14.6M | 0.18% | 104 |
|
|
2018
Q2 | $223M | Sell |
2,024,273
-293,256
| -13% | -$30.5M | 0.22% | 84 |
|
|
2018
Q1 | $232M | Buy |
2,317,529
+177,299
| +8% | +$18.2M | 0.22% | 83 |
|
|
2017
Q4 | $211M | Buy |
2,140,230
+114,752
| +6% | +$10.9M | 0.17% | 118 |
|
|
2017
Q3 | $190M | Buy |
2,025,478
+193,475
| +11% | +$20.5M | 0.16% | 119 |
|
|
2017
Q2 | $203M | Sell |
1,832,003
-197,387
| -10% | -$20.9M | 0.2% | 98 |
|
|
2017
Q1 | $199M | Sell |
2,029,390
-367,174
| -15% | -$35M | 0.19% | 94 |
|
|
2016
Q4 | $220M | Sell |
2,396,564
-1,018,541
| -30% | -$87.8M | 0.2% | 100 |
|
|
2016
Q3 | $288M | Sell |
3,415,105
-169,160
| -5% | -$14.2M | 0.28% | 56 |
|
|
2016
Q2 | $292M | Sell |
3,584,265
-922,487
| -20% | -$70.2M | 0.31% | 53 |
|
|
2016
Q1 | $322M | Buy |
4,506,752
+318,345
| +8% | +$21.3M | 0.37% | 49 |
|
|
2015
Q4 | $298M | Buy |
4,188,407
+3,442,605
| +462% | +$231M | 0.34% | 56 |
|
|
2015
Q3 | $45.8M | Sell |
745,802
-34,060
| -4% | -$2.38M | 0.05% | 409 |
|
|
2015
Q2 | $56.6M | Buy |
779,862
+140,707
| +22% | +$10.4M | 0.06% | 386 |
|
|
2015
Q1 | $49.1M | Buy |
639,155
+232,329
| +57% | +$16.6M | 0.06% | 371 |
|
|
2014
Q4 | $27.3M | Buy |
406,826
+64,817
| +19% | +$4.09M | 0.03% | 602 |
|
|
2014
Q3 | $20.8M | Buy |
342,009
+142,186
| +71% | +$8.76M | 0.03% | 627 |
|
|
2014
Q2 | $11.7M | Buy |
199,823
+30,420
| +18% | +$1.78M | 0.01% | 702 |
|
|
2014
Q1 | $9.81M | Buy |
169,403
+270
| +0.2% | +$14.5K | 0.01% | 761 |
|
|
2013
Q4 | $9.06M | Buy |
169,133
+56,355
| +50% | +$3.34M | 0.01% | 766 |
|
|
2013
Q3 | $6.97M | Buy |
112,778
+5,808
| +5% | +$348K | 0.01% | 808 |
|
|
2013
Q2 | $6.49M | Buy |
+106,970
| New | +$6.37M | 0.01% | 788 |
|
Other funds holding DGX
VCM
VPM
EIG
Allianz Asset Management's DGX Position: Q1 2026 in Review
Allianz Asset Management reduced its Quest Diagnostics (DGX) stake by 43% in Q1 2026, selling an estimated $5.38M and leaving 36,990 shares worth $7.25M. The position accounts for 0.01% of the portfolio, ranked #1002.
Allianz Asset Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $322M in Q1 2016. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Allianz Asset Management held 36,990 shares of Quest Diagnostics worth $7.25M as of Q1 2026.
- Allianz Asset Management sold 27,716 Quest Diagnostics shares in Q1 2026, an estimated $5.38M.
- Quest Diagnostics made up 0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1002 holding.
- Allianz Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Quest Diagnostics position peaked at $322M in Q1 2016.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.